Dr. Pathak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Washington St
Wilmington, DE 19801Phone+1 302-655-7110Fax+1 302-655-6185
Education & Training
Cincinnati Children's Hospital Medical CenterFellowship, Child and Adolescent Psychiatry, 1999 - 2001
University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1996 - 1999
All India Institute of Medical SciencesClass of 1992
Certifications & Licensure
OH State Medical License 1999 - 2026
DE State Medical License 2010 - 2015
Clinical Trials
- A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD) Start of enrollment: 2014 Feb 01
- A Long-Term Safety Study of ALKS 5461 Start of enrollment: 2014 May 01
- A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial.Daniel Weintraub, Alberto J Espay, Vibhash D Sharma, Pierre N Tariot, Victor Abler
Parkinsonism & Related Disorders. 2024-02-01 - Challenges and proposed solutions to conducting Alzheimer's disease psychosis trials.Clive Ballard, Pierre Tariot, Maria Soto-Martin, Sanjeev Pathak, I-Yuan Liu
Frontiers in Psychiatry. 2024-01-01 - 48 citationsOpioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.Maurizio Fava, Michael E. Thase, Madhukar H. Trivedi, Elliot Ehrich, William F. Martin
Molecular Psychiatry. 2020-07-01
Authored Content
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
- S99. Evaluation of Abuse Potential of Samidorphan in Healthy, Nondependent, Recreational Opioid UsersApril 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
